Close Menu

NEW YORK – Australian diagnostics firm Sienna Cancer Diagnostics said on Thursday it appointed Immuno Diagnostic its exclusive distributor in Finland.

As part of the agreement, Immuno Diagnostic, based in Hämeenlinna, Finland, will have the right to sell Sienna's CE-marked hTERT (human telomerase reverse transcriptase) test to Finnish pathology labs to help diagnose bladder cancer. About 1,200 new cases of the disease are diagnosed in Finland each year, Sienna noted.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.